Table 3.
Variable | Univariate analysis
|
Multivariate analysis
|
||
---|---|---|---|---|
Crude odds ratio (95% CI) | p Value | Adjusted odds ratio (95% CI) | p Value | |
Age | 1.03 (0.99–1.05) | 0.066 | 1.03 (0.99–1.06) | 0.08 |
| ||||
Male gender | 1.23 (0.59–2.59) | 0.58 | ||
| ||||
Diabetes | 0.64 (0.28–1.49) | 0.30 | ||
| ||||
ASA score | ||||
| ||||
2 | Reference | Reference | ||
| ||||
3 | 1.32 (0.58–3.02) | 0.51 | 1.27 (0.53–3.01) | 0.70 |
| ||||
4 | 5.81 (1.59–21.23) | 0.008* | 4.31 (1.06–17.49) | 0.041* |
| ||||
Platelet count <150/nL | 2.43 (1.15–5.13) | 0.020* | 2.77 (1.13–6.76) | 0.026* |
| ||||
Child score | 1.41 (1.02–1.96) | 0.040* | 1.09 (0.73–1.64) | 0.68 |
| ||||
MELD score | 1.09 (1.00–1.18) | 0.046* | 1.08 (0.98–1.20) | 0.21 |
| ||||
Ruptured lesion | 0.69 (0.15–3.15) | 0.63 | ||
| ||||
Tumor >Milan criteria | 2.56 (1.02–6.44) | 0.045* | 3.95 (1.43–10.94) | 0.008* |
| ||||
Major resection | 0.64 (0.32–1.27) | 0.20 |
Statistically significant p values.
ASA, American Society of Anesthesiologists; MELD, model for end-stage liver disease.